Enzyferm Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Enzyferm General Information

Description

Developer of multi-organism fermentation technology designed for sustainable fermentation production purposes. The company incorporates diverse yeast strains, non-yeast fungi, and bacteria for fermentation, reducing energy consumption, raw material waste, and eliminating the need for chemical additives, enabling beverage and food producers to achieve sustainable output with enhanced flavor complexity and a reduced environmental impact.

Contact Information

Website
enzyferm.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gaustadalléen 21
  • 0349 Oslo
  • Norway
Primary Industry
Biotechnology
Other Industries
Other Commercial Products
Vertical(s)
Life Sciences
Corporate Office
  • Gaustadalléen 21
  • 0349 Oslo
  • Norway

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzyferm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 03-Feb-2025 Completed Generating Revenue
2. Early Stage VC 01-Jan-2024 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Enzyferm’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Enzyferm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzyferm Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Protonic Partners Venture Capital Minority
Gilbert & Partners Venture Capital Minority
ShareLab Incubator Accelerator/Incubator
To view Enzyferm’s complete investors history, request access »

Ready to get started?

Request a free trial

Enzyferm FAQs

  • When was Enzyferm founded?

    Enzyferm was founded in 2023.

  • Where is Enzyferm headquartered?

    Enzyferm is headquartered in Oslo, Norway.

  • What is the size of Enzyferm?

    Enzyferm has 7 total employees.

  • What industry is Enzyferm in?

    Enzyferm’s primary industry is Biotechnology.

  • Is Enzyferm a private or public company?

    Enzyferm is a Private company.

  • What is Enzyferm’s current revenue?

    The current revenue for Enzyferm is .

  • Who are Enzyferm’s investors?

    Protonic Partners, Gilbert & Partners, and ShareLab Incubator have invested in Enzyferm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process